Immunohistochemical assessment for Cdx2 expression in the Barrett metaplasia-dysplasia-adenocarcinoma sequence

被引:26
作者
Hayes, Stephen [1 ]
Ahmed, Sajad [1 ]
Clark, Peter [1 ]
机构
[1] Salford Royal NHS Fdn Trust, Dept Histopathol, Salford M6 8HD, Lancs, England
关键词
HOMEOBOX GENE; INTESTINAL DEVELOPMENT; ESOPHAGUS; DIAGNOSIS; MARKER; DIFFERENTIATION; PROGRESSION; EPITHELIUM; CANCER;
D O I
10.1136/jcp.2010.075945
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background Barrett oesophagus (BO) occurs as a consequence of prolonged gastro-oesophageal reflux and it may precede the development of oesophageal adenocarcinoma. Aims The aim of this study was to accurately assess Cdx2 expression in the oesophageal metaplasia-dysplasia-adenocarcinoma sequence. Method The expression of the transcription factor Cdx2 in Barrett metaplasia, high-grade glandular dysplasia and adenocarcinoma was investigated using immunohistochemistry. Results The results confirmed previous immunohistochemistry and PCR-based investigations, indicating that Cdx2 was expressed by intestinal metaplasia in the oesophagus. In addition, upregulation followed by linear downregulation of Cdx2 expression through the oesophageal metaplasia-dysplasia-adenocarcinoma sequence was demonstrated for the first time. Conclusion Such downregulation of Cdx2 expression could be in keeping with a role as a tumour suppressor gene, but a simpler explanation would be downregulation of a differentiation marker.
引用
收藏
页码:110 / 113
页数:4
相关论文
共 21 条
[1]   The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development [J].
Bonhomme, C ;
Duluc, I ;
Martin, E ;
Chawengsaksophak, K ;
Chenard, MP ;
Kedinger, M ;
Beck, F ;
Freund, JN ;
Domon-Dell, C .
GUT, 2003, 52 (10) :1465-1471
[2]   Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa [J].
Eda, A ;
Osawa, H ;
Satoh, K ;
Yanaka, I ;
Kihira, K ;
Ishino, Y ;
Mutoh, H ;
Sugano, K .
JOURNAL OF GASTROENTEROLOGY, 2003, 38 (01) :14-22
[3]   Expression of the intestinal marker Cdx2 in the columnar-lined esophagus with and without intestinal (Barrett's) metaplasia [J].
Groisman, GM ;
Amar, M ;
Meir, A .
MODERN PATHOLOGY, 2004, 17 (10) :1282-1288
[4]   The role of Cdx proteins in intestinal development and cancer [J].
Guo, RJ ;
Suh, ER ;
Lynch, JP .
CANCER BIOLOGY & THERAPY, 2004, 3 (07) :593-601
[5]   Roles of caudal-related homeobox gene Cdx1 in oesophageal epithelial cells in Barrett's epithelium development [J].
Kazumori, H. ;
Ishihara, S. ;
Kinoshita, Y. .
GUT, 2009, 58 (05) :620-628
[6]   Grading of dysplasia in Barrett's oesophagus:: substantial interobserver variation between general and gastrointestinal pathologists [J].
Kerkhof, M. ;
van Dekken, H. ;
Steyerberg, E. W. ;
Meijer, G. A. ;
Mulder, A. H. ;
de Bruine, A. ;
Driessen, A. ;
ten Kate, F. J. ;
Kusters, J. G. ;
Kuipers, E. J. ;
Siersema, P. D. .
HISTOPATHOLOGY, 2007, 50 (07) :920-927
[7]   CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer [J].
Liu, Qiang ;
Teh, Ming ;
Ito, Kosei ;
Shah, Nilesh ;
Ito, Yoshiaki ;
Yeoh, Khay Guan .
MODERN PATHOLOGY, 2007, 20 (12) :1286-1297
[8]   Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma [J].
Lord, RVN ;
Brabender, J ;
Wickramasinghe, K ;
DeMeester, SR ;
Holscher, A ;
Schneider, PM ;
Danenberg, PV ;
DeMeester, TR .
SURGERY, 2005, 138 (05) :924-931
[9]  
Mallo GV, 1997, INT J CANCER, V74, P35, DOI 10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO
[10]  
2-1